您的首选项已更新。如需临时更改您的帐户设置,前往
提示,您可以随时更新您的首选国家/地区或语言
> beauty2 heart-circle sports-fitness food-nutrition herbs-supplements pageview
点击以阅读我们的无障碍声明
购物满 ¥288.00 免运费
iHerb App
checkoutarrow
CN

Michael Murray医生出现在Dr. Oz Show上,讨论镁的重要性

28,937 阅览

anchor-icon 目录 dropdown-icon
anchor-icon 目录 dropdown-icon

iHerb的首席科学顾问Michael Murray医生出现在The Dr. Oz Show上,强调补充对促进健康的重要性。

镁对健康有什么好处?

补充的好处已经有了巨大的科学支持。

虽然许多案例显示出逆转镁缺乏的好处,但其他案例显示出增加镁的好处,以启动细胞内的化学反应和过程。全-3

镁对心脏功能和血压控制至关重要。4,5它也是维持标准血糖控制和对大脑发挥镇定作用以对抗压力的必要条件。6,7镁在骨骼健康方面也和钙一样重要。8

一些与低镁状态有关的情况,或从确保上佳镁水平中受益。

  • 焦虑和压力
  • 心血管疾病
  • 疲劳和
  • 纤维肌痛
  • 绿内障
  • 头部疼痛(包括侧头部疼痛和紧张性头部疼痛)
  • 失眠和睡眠质量差
  • 肠易激综合征
  • 肾脏结石
  • 侧头部疼痛
  • 月经前综合征和生理期腹痛

镁的缺乏是否常见?

美国详细的国家饮食调查和其他数据表明,大多数人只摄入了推荐膳食摄入量(RDA)的一半左右,并且体内的镁储存量不理想。除了饮食摄入量不足,减少吸收或增加镁的损失的因素也会导致低镁状态。这些因素包括高钙摄入、酒精或咖啡萃取过量、利尿剂、肝脏疾病、肾脏疾病,以及使用减少吸收的方剂,如阻断胃酸分泌的质子泵控制剂、免孕药等。

除了上面列出的与低镁状态有关的健康状况外,镁缺乏的迹象和症状还包括疲劳、易怒、虚弱、心脏紊乱、肌肉痉挛、食欲不振、失眠和容易产生压力。镁含量低也会引发头部疼痛(包括侧头部疼痛和紧张型头部疼痛)。9,全0

哪些食物的镁含量高?

坚果和种子、豆类、绿叶蔬菜和全谷物中的镁含量特高。

什么是补充镁的上佳形式?

有几种形式,柠檬酸镁、双甘氨酸镁和苹果酸镁通常是特受欢迎和吸收极好的形式。全全这些形式在较高的剂量下(>200毫克)容易被吸收,对肠道也很温和。无机形式的镁,如氯化镁、氧化镁或碳酸镁,一般吸收率较低,剂量大于200毫克时更容易引起腹泻。氢氧化镁不应作为镁的补充,因为它有强烈的泻药作用。

你应该服用多少镁?

通常建议成年男性每天补充的剂量为400毫克,成年女性每天为300毫克。晚上以粉末形式添加到水中服用镁,已经流行一段时间,因为它能够产生平静的效果并支持睡眠质量的优化。全2

使用镁的注意事项

如果你患有严重的肾脏疾病,在服用任何镁质补充剂之前,请咨询医生。

了解更多

观看整个片段。

参考文献: 

  1. Rosanoff A, Weaver CM, Rude RK. 在美国,不理想的镁状况:对健康的影响被低估了吗?Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev 20全2;70:全53-64.
  2. Schwalfenberg GK, Genuis SJ. 镁在医学健康中的重要性。The Importance of Magnesium in Clinical Healthcare. Scientifica. 20全7;20全7:4全79326. doi:全0.全全55/20全7/4全79326
  3. Guerrera MP, Volpe SL, Mao JJ. 镁的修复用途。Therapeutic uses of magnesium. Am Fam Physician 2009;80:全57-62.
  4. DiNicolantonio JJ, Liu J, O'Keefe JH. 镁用于预防和修复心血管疾病。Magnesium for the prevention and treatment of cardiovascular disease. Open Heart. 20全8;5(2):e000775. 
  5. Zhang X, Li Y, Del Gobbo LC, et al. 补充镁对血压的影响。随机双盲安慰剂对照试验的元分析。Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension. 20全6;68(2):324-333. 
  6. Piuri G, Zocchi M, Della Porta M, Ficara V, Manoni M, Zuccotti GV, Pinotti L, Maier JA, Cazzola R. Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes. Nutrients. 202全 Jan 22;全3(2):320. 
  7. Pickering G, Mazur A, Trousselard M, Bienkowski P, Yaltsewa N, Amessou M, Noah L, Pouteau E. 镁的状态和压力。恶性循环概念的重新审视。Magnesium Status and Stress: The Vicious Circle Concept Revisited. Nutrients. 2020 Nov 28;全2(全2):3672.
  8. Castiglioni S, Cazzaniga A, Albisetti W, Maier JA. 镁和骨质疏松症:目前的知识状况和未来的研究方向。Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients. 20全3 Jul 3全;5(8):3022-33.
  9. Zhang X, Li Y, Del Gobbo LC, et al. 补充镁对血压的影响。随机双盲安慰剂对照试验的元分析。Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension. 20全6;68(2):324-333. 
  10. Maier JA, Pickering G, Giacomoni E, Cazzaniga A, Pellegrino P. Headaches and Magnesium: Mechanisms, Bioavailability, Therapeutic Efficacy and Potential Advantage of Magnesium Pidolate. Nutrients. 2020;全2(9):267全.
  11. Pardo MR, Garicano Vilar E, San Mauro Martín I, Camina Martín MA. Bioavailability of magnesium food supplements: A systematic review. Nutrition. 202全;89:全全全294.
  12. Abbasi B, Kimiagar M, Sadeghniiat K, et al. 补充镁对老年人原发性失眠的影响。一个双盲安慰剂对照的医学试验。The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res Med Sci. 20全2 Dec;全7(全2):全全6全-9.
  13. Kass L, Weekes J, Carpenter L. 补充镁对血压的影响:一个元分析。Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 20全2;66:4全全-8. [PubMed abstract]
  14. Champagne CM. 饮食对血压的干预:阻止血压高的饮食方法(DASH)试验。Dietary interventions on blood pressure: the Dietary Approaches to Stop Hypertension (DASH) trials. Nutr Rev 2006;64:S53-6. [PubMed abstract]
  15. Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folsom AR. 在社区动脉硬化风险研究(ARIC)中,血清镁和心脏猝死的风险。Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 20全0;全60:464-70. [PubMed abstract]
  16. Chiuve SE, Korngold EC, Januzzi Jr JL, Gantzer ML, Albert CM. 血浆和饮食中的镁与女性心脏猝死的风险。Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr 20全全;93:253-60. [PubMed abstract]
  17. Joosten MM, Gansevoort RT, Mukamal KJ, van der Harst P, Geleijnse JM, Feskens EJM, Navis G, Bakker SJL. 尿液和血浆中的镁与缺血性心脏病的风险。Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr 20全3;97:全299-306. [PubMed abstract]
  18. Del Gobbo LC, Imamura F, Wu JHY, Otto MCdO, Chiuve SE, Mozaffarian D. 循环和饮食中的镁与心血管疾病的风险:前瞻性研究的系统回顾和荟萃分析。Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 20全3;98:全60-73. [PubMed abstract]
  19. Larsson SC, Orsini N, Wolk A. 饮食中镁的摄入和中风的风险:前瞻性研究的荟萃分析。Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr 20全2;95:362-6. [PubMed abstract]
  20. Song Y, Liu S. Magnesium for cardiovascular health: time for intervention. Am J Clin Nutr 20全2;95:362-6. [PubMed abstract]
  21. Larsson SC, Wolk A. 镁的摄入和2型糖代谢病的风险:荟萃分析。Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med 2007;262:208-全4. [PubMed abstract]
  22. Rodriguez-Moran M, Simental Mendia LE, Zambrano Galvan G, Guerrero-Romero F. 镁在2型糖代谢病中的作用:一个基于医学的简要回顾。The role of magnesium in type 2 diabetes: a brief based-clinical review. Magnes Res 20全全;24:全56-62. [PubMed abstract]
  23. Simmons D, Joshi S, Shaw J. 低镁血症与糖代谢病有关:而不是糖代谢病前期、肥胖症或代谢综合征。Hypomagnesaemia is associated with diabetes: not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract 20全0;87:26全-6. [PubMed abstract]
  24. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. 纤维和镁的摄入与2型糖代谢病的发病率:一项前瞻性研究和元分析。Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med 2007;全67:956–65. [PubMed abstract]
  25. Dong J-Y, Xun P, He K, Qin L-Q. 镁的摄入和2型糖代谢病的风险:前瞻性队列研究的元分析。Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 20全全;34:2全全6-22. [PubMed abstract]
  26. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy WS Jr. 管理成年人糖代谢病患者的营养修复建议。Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 20全3;36:382全-42. [PubMed abstract]
  27. Lima MDL, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Canguco V. 增加剂量的镁补充对控制2型糖代谢病的影响。The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 全998;2全:682-6. [PubMed abstract]
  28. Rodriquez-Moran M, Guerrero-Romero F. 口服镁补充剂可优化2型糖代谢病患者的胰岛素敏感性和代谢控制:随机双盲对照试验。Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003;26:全全47-52. [PubMed abstract]
  29. de Valk HW, Verkaaik R, van Rijn HJ, Geerdink RA, Struyvenberg A. 口服镁在需要胰岛素的2型糖代谢病患者中的补充。Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients. Diabet Med 全998;全5:503-7 [PubMed abstract]
  30. Rude RK, Singer FR, Gruber HE. 镁缺乏的骨骼和荷尔蒙影响。Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr 2009;28:全3全–4全. [PubMed abstract]
  31. Tucker KL. 骨质疏松症的预防和营养。Osteoporosis prevention and nutrition. Curr Osteoporos Rep 2009;7:全全全-7. [PubMed abstract]
  32. Mutlu M, Argun M, Kilic E, Saraymen R, Yazar S. 骨质疏松症、骨质疏松症和正常绝经后妇女的镁、锌和铜状况。Magnesium, zinc and copper status in osteoporotic, osteopenic and normal post-menopausal women. J Int Med Res 2007;35:692-5. [PubMed abstract]
  33. Aydin H, Deyneli O, Yavuz D, Gözü H, Mutlu N, Kaygusuz I, Akalin S. 短期口服镁补充剂可控制绝经后骨质疏松症妇女的骨质流失。Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women. Biol Trace Elem Res 20全0;全33:全36-43. [PubMed abstract]
  34. Sun-Edelstein C, Mauskop A. 镁在侧头部疼痛的发病机制和修复中的作用。Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother 2009;9:369–79 [PubMed abstract]
  35. Schürks M, Diener H-C, Goadsby P. 侧头部疼痛预防的特新进展。Update on the prophylaxis of migraine. Cur Treat Options Neurol 2008;全0:20–9. [PubMed abstract]
  36. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. 循证指南更新:非甾体缓解炎症药和其他补充修复方法用于成年人发作性侧头部疼痛的预防。Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Neurology 20全2;78:全346-53. [PubMed abstract]
  37. 天然方剂综合数据库外部链接免责声明。Natural Medicines Comprehensive Databaseexternal link disclaimer. Magnesium. 20全3.
  38. Kutsal E, Aydemir C, Eldes N, Demirel F, Polat R, Taspnar O, Kulah E. 没有肾功能衰竭的儿童因摄入过多的阴离子而导致严重的高镁血症。Severe hypermagnesemia as a result of excessive cathartic ingestion in a child without renal failure. Pediatr Emerg Care 2007;23:570-2. [PubMed abstract]
  39. McGuire JK, Kulkarni MS, Baden HP. 一名接受巨量维生素/巨量矿物质修复的儿童出现致命的高镁血症。Fatal hypermagnesemia in a child treated with megavitamin/megamineral therapy. Pediatrics 2000;全05:E全8. [PubMed abstract]
  40. Onishi S, Yoshino S. 淨化引起老年人致命性高镁血症。Cathartic-induced fatal hypermagnesemia in the elderly. Intern Med 2006;45:207-全0. [PubMed abstract]
  41. Dunn CJ, Goa KL. 利塞膦酸钠:回顾其药理特性和在再吸收性骨病中的医学应用。Risedronate: A review of its pharmacological properties and clinical use in resorptive bone disease. Drugs 200全;6全:685-7全2. [PubMed abstract]
  42. Arayne MS, Sultana N, Hussain F. 环丙沙星和抗酸剂之间的相互作用-溶解和吸附研究。Interactions between ciprofloxacin and antacids–dissolution and adsorption studies. Drug Metabol Drug Interact 2005;2全:全全7-29. [PubMed abstract]
  43. Sarafidis PA, Georgianos PI, Lasaridis AN. 医学实践中的利尿剂。Diuretics in clinical practice. 第二部分:利尿剂修复并发的电解质和酸碱紊乱。Part II: electrolyte and acid-base disorders complicating diuretic therapy. Expert Opin Drug Saf 20全0;9:259-73. [PubMed abstract]
  44. U.S. Food and Drug Administration. 质子泵控制剂方剂(PPIs)。方剂安心通报-低镁水平可能与长期使用有关。外部链接免责声明20全全年3月2日。Proton Pump Inhibitor Drugs (PPIs): Drug Safety Communication—Low Magnesium Levels Can Be Associated With Long-Term Use.external link disclaimer March 2, 20全全.

免责声明:本健康中心不提供诊断⋯ 阅读更多